Health: Cholesterol's One-Two Punch

Millions of Americans already take a drug to lower their LDL, or bad cholesterol, but if things go Pfizer's way, they may end up adding a pill that raises HDL, the good cholesterol that helps keep arteries clean. A study in the current New England Journal of Medicine reports that the drug torcetrapib boosted HDL levels 46%. When it was combined with the LDL-lowering drug Lipitor, the results were even more dramatic: HDL levels rose 61%, and LDL fell even more than it did with Lipitor alone. But will raising HDL levels mean lower rates of heart disease and fewer deaths? That's what Pfizer hopes to show. If it does, both the drug company and patients could be big winners.

--D.B.

Quotes of the Day »

RAY KELLY, New York City Police Commissioner, on the arrest of a New Jersey man in one of the nation's most baffling missing-children cases, the disappearance more than three decades ago of 6-year-old Etan Patz.
For use in rail of Articles page or Section Fronts pages. Duplicate and change name as necesssary to distinguish.